Authors:
Chakrabarti, S
Collingham, KE
Osman, H
Fegan, CD
Milligan, DW
Citation: S. Chakrabarti et al., Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections, BONE MAR TR, 28(9), 2001, pp. 879-881
Authors:
Chakrabarti, S
Collingham, KE
Holder, K
Fegan, CD
Osman, H
Milligan, DW
Citation: S. Chakrabarti et al., Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study, BONE MAR TR, 28(8), 2001, pp. 759-763
Citation: S. Chakrabarti et al., T cell-depleted nonmyeloablative stem cell transplantation: what is the optimum balance between the intensity of host conditioning and the degree of T cell depletion of the graft?, BONE MAR TR, 28(3), 2001, pp. 313-314
Authors:
Robertson, JD
Testa, NG
Russell, NH
Jackson, G
Parker, AN
Milligan, DW
Stainer, C
Chakrabarti, S
Dougal, M
Chopra, R
Citation: Jd. Robertson et al., Accelerated telomere shortening following allogeneic transplantation is independent of the cell source and occurs within the first year post transplant, BONE MAR TR, 27(12), 2001, pp. 1283-1286
Authors:
Chakrabarti, S
Collingham, KE
Marshall, T
Holder, K
Gentle, T
Hale, G
Fegan, CD
Milligan, DW
Citation: S. Chakrabarti et al., Respiratory virus infections in adult T cell-depleted transplant recipients: The role of cellular immunity, TRANSPLANT, 72(8), 2001, pp. 1460-1463
Authors:
Chakrabarti, S
Handa, SK
Bryon, RJ
Griffiths, MJ
Milligan, DW
Citation: S. Chakrabarti et al., Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?, TRANSPLANT, 72(2), 2001, pp. 340-342
Authors:
Keenan, RD
Ainsworth, J
Khan, N
Bruton, R
Cobbold, M
Assenmacher, M
Milligan, DW
Moss, PAH
Citation: Rd. Keenan et al., Purification of cytomegalovirus-specific CD8 T cells from peripheral bloodusing HLA-peptide tetramers, BR J HAEM, 115(2), 2001, pp. 428-434
Authors:
Miflin, G
Russell, NH
Franklin, I
Cook, G
Milligan, DW
Hutchinson, RM
Potter, MN
Morgan, GJ
Pagliuca, A
Marsh, J
Bell, A
Citation: G. Miflin et al., An analysis of the effect of chronic GvHD on relapse and survival following allogeneic PBSC transplantation, CYTOTHERAPY, 2(6), 2000, pp. 423-428
Authors:
Chakrabarti, S
Collingham, KE
Holder, K
Oyaide, S
Pillay, D
Milligan, DW
Citation: S. Chakrabarti et al., Parainfluenza virus type 3 infections in hematopoetic stem cell transplantrecipients: Response to ribavirin therapy, CLIN INF D, 31(6), 2000, pp. 1516-1518
Citation: Dw. Milligan, Secondary leukaemia and myelodysplasia after autografting for lymphoma: Isthe transplant to blame?, LEUK LYMPH, 39(3-4), 2000, pp. 223-228
Authors:
Chakrabarti, S
Lees, A
Jones, SG
Milligan, DW
Citation: S. Chakrabarti et al., Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality, BONE MAR TR, 26(8), 2000, pp. 871-876
Authors:
Chakrabarti, S
Collingham, KE
Fegan, CD
Pillay, D
Milligan, DW
Citation: S. Chakrabarti et al., Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy?, BONE MAR TR, 26(3), 2000, pp. 305-307
Authors:
Chakrabarti, S
Collingham, KE
Stevens, RH
Pillay, D
Fegan, CD
Milligan, DW
Citation: S. Chakrabarti et al., Isolation of viruses from stools in stem cell transplant recipients: a prospective surveillance study, BONE MAR TR, 25(3), 2000, pp. 277-282
Authors:
Chakrabarti, S
Pillay, D
Ratcliffe, D
Cane, PA
Collingham, KE
Milligan, DW
Citation: S. Chakrabarti et al., Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: Risk factors and prognostic significance, J INFEC DIS, 181(6), 2000, pp. 2055-2058
Authors:
Kottaridis, PD
Milligan, DW
Chopra, R
Chakraverty, RK
Chakrabarti, S
Robinson, S
Peggs, K
Verfuerth, S
Pettengell, R
Marsh, JCW
Schey, S
Mahendra, P
Morgan, GJ
Hale, G
Waldmann, H
de Elvira, MCR
Williams, CD
Devereux, S
Linch, DC
Goldstone, AH
Mackinnon, S
Citation: Pd. Kottaridis et al., In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation, BLOOD, 96(7), 2000, pp. 2419-2425
Authors:
Gahrton, G
Svensson, H
Bjorkstrand, B
Apperley, J
Carlson, K
Cavo, M
Ferrant, A
Fouillard, L
Gratecos, N
Gratwohl, A
Guilhot, F
Deliliers, GL
Ljungman, P
Masszi, T
Milligan, DW
Powles, RL
Reiffers, J
Samson, JD
Stoppa, AM
Vernant, JP
Volin, L
Wallvik, J
Citation: G. Gahrton et al., Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation, BONE MAR TR, 24(7), 1999, pp. 741-745
Authors:
Chakrabarti, S
Collingham, KE
Fegan, CD
Milligan, DW
Citation: S. Chakrabarti et al., Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy, BONE MAR TR, 23(11), 1999, pp. 1209-1211
Authors:
Milligan, DW
de Elvira, MCR
Kolb, HJ
Goldstome, AH
Meloni, GA
Rohatiner, AZ
Colombat, P
Schmitz, N
Citation: Dw. Milligan et al., Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT, BR J HAEM, 106(4), 1999, pp. 1020-1026
Authors:
Brouwer, RE
Vellenga, E
Zwinderman, KH
Bezwoda, WR
Durrant, STS
Herrmann, RP
Kiese, B
Maraninchi, D
Milligan, DW
Sklenar, I
Tabilio, A
Volonte, JLP
Winfield, DA
Fibbe, WE
Citation: Re. Brouwer et al., Phase III efficacy study of interleukin-3 after autologous bone marrow transplantation in patients with malignant lymphoma, BR J HAEM, 106(3), 1999, pp. 730-736